{
"NDC": {
"NDCCode": "64980-206-12",
"PackageDescription": "120 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-206-12) ",
"NDC11Code": "64980-0206-12",
"ProductNDC": "64980-206",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Zileuton",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Zileuton",
"DosageFormName": "TABLET, EXTENDED RELEASE",
"RouteName": "ORAL",
"StartMarketingDate": "20170321",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA204929",
"LabelerName": "Rising Pharma Holdings, Inc.",
"SubstanceName": "ZILEUTON",
"StrengthNumber": "600",
"StrengthUnit": "mg/1",
"Pharm_Classes": "5-Lipoxygenase Inhibitor [EPC], 5-Lipoxygenase Inhibitors [MoA], Decreased Leukotriene Production [PE]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2024-05-24",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20170321",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}